(Q73494763)
Statements
Dose-finding study and pharmacokinetics of epirubicin and paclitaxel over 3 hours: a regimen with high activity and low cardiotoxicity in advanced breast cancer (English)
E Baldini
A Michelotti
B Salvadori
C Tibaldi
F Innocenti
A Gentile
R Dell'Anna
O Biadi
M Mariani